MedTrace Logo

To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia

NCT00726362 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3270

Last updated 2010-12-03

No results posted yet for this study

Summary

The primary objective is to survey the efficacy of various commercially available statins (a class of lipid-lowering agents, for example, rosuvastatin, atorvastatin, simvastatin, lovastatin, pravastatin and fluvastatin) under local clinical practice in treating patients with hyperlipidemia. Surveillance data (Lipid Profile) will be collected during course of usual clinical practice or captured upon its availability.

Conditions

  • Hyperlipidemias

Sponsors & Collaborators

Principal Investigators

  • Wen-Ter Lai, MD · Kaohsiung Medical University

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00726362 on ClinicalTrials.gov